DATATRAK International, Inc. (OTCQX: DTRK) is a worldwide technology services company delivering unified eClinical® solutions and related services designed to safely accelerate every drug, biologic and device from concept to cure. The company’s proprietary DATATRAK ONE® Unified Experience™ platform provides users with an all-in one clinical enterprise solution complete with all of the necessary components to effectively design, deliver and manage clinical trials. DATATRAK’s groundbreaking software solution currently supports preclinical through phase IV drug and device studies in multiple languages around the world.
Earlier this month, DATATRAK built on its industry-leading software suite through the introduction of UX CTMS 360™. Using this revolutionary startup solution, clinical trials can be initiated at the click of a button without the need for programming expertise. By effectively eliminating the risks and time required to integrate data across multiple systems, the company’s clinical trial management system provides clients with an immediate return on investment.
“The industry has struggled long enough with data silos and expensive third party consulting fees,” Laurence P. Birch, chairman and chief executive officer of DATATRAK, stated in a news release. “With the introduction of UX CTMS 360, we strip away that complexity and expense… [providing] an immediate view of all clinical and operational data across studies.”
In recent months, DATATRAK has made significant progress toward expanding its market share in the life sciences market. In the first quarter of 2015, the company recorded a 35 percent year-over-year increase in new contract sales as a result of continued investment in sales and marketing efforts. This increase in contract sales resulted in a backlog of $27.8 million, an increase of 7 percent over the end of 2014. In April, the company laid the groundwork for continued improvement in the future by opening its Chicago office, expanding its physical presence in one of the country’s leading life sciences markets.
“The success we’re seeing in new contract sales is a positive for the business overall,” continued Birch. “New clients often become our most dedicated partners, setting the stage for future revenue growth.”
For more information, visit www.datatrak.com
